{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Nigella sativa", "nanoparticles", "nanotechnology", "neurodegenerative diseases", "thymoquinone"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37786518", "DateRevised": {"Year": "2023", "Month": "10", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.1002/ibra.12091"], "Journal": {"ISSN": "2769-2795", "JournalIssue": {"Volume": "9", "Issue": "1", "PubDate": {"Year": "2023", "Season": "Spring"}}, "Title": "Ibrain", "ISOAbbreviation": "Ibrain"}, "ArticleTitle": "<i>Nigella sativa</i> and its nano-mediated approach toward\u00a0management of neurodegenerative disorders: A review.", "Pagination": {"StartPage": "111", "EndPage": "123", "MedlinePgn": "111-123"}, "Abstract": {"AbstractText": ["<i>Nigella sativa</i> L., also known as black seed or black cumin, is a plant that has been used for centuries. In the past, this flowering plant was used as a food preservative and medicinal herb. A vital component of <i>Nigella\u00a0sativa</i>, thymoquinone (TQ), plays a significant therapeutic role in the management of most diseases, including cancer, diabetes mellitus, hypertension, inflammation, gastrointestinal disorders, and neurodegenerative disorders. Neurodegenerative disorders are primarily caused by neurotransmitter hypoactivity, particularly insufficient serotonin activity. It has been discovered that many medicinal herbs and their active compounds have therapeutic value. Black cumin seeds have been used to heal ailments and its history traces back to ancient times such as ancient Babylonia. They can be used applied to alleviate edema, hair loss, and bruising, and consumd to treat stomach issues. It is one of the most feasible and effective medicinal plants. The use of nanoformulations based on <i>Nigella\u00a0sativa</i> and TQ to treat neurodegenerative diseases (NDs) has yielded promising outcomes. Customized administration of nanoparticle (NP) systems and nanomedicine are two of the many options for drug delivery to the central nervous system (CNS) that are attracting increasing interest. Delivering a therapeutic and diagnostic substance to a particular location is the core target of NPs. Because of their distinct cell uptake and trafficking mechanisms, NPs can reduce the amount that accumulates in undesirable organs. The focus of the current review is on recent studies on the various neuroprotective properties of <i>Nigella\u00a0sativa</i> as well as nanoformulations for NDs and the brain's uptake of NPs. The review summarizes the In vivo, In vitro, and In silico studies on the protective effects of black cumin against neurodegenerative disorders."], "CopyrightInformation": "\u00a9 2023 The Authors. Ibrain published by Affiliated Hospital of Zunyi Medical University and Wiley\u2010VCH GmbH."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth Pune Maharashtra India."}], "LastName": "Gawas", "ForeName": "Chaitali G", "Initials": "CG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth Pune Maharashtra India."}], "LastName": "Mathur", "ForeName": "Sakshi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth Pune Maharashtra India."}], "LastName": "Wani", "ForeName": "Minal", "Initials": "M"}, {"Identifier": ["0000-0002-3632-0984"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth Pune Maharashtra India."}], "LastName": "Tabassum", "ForeName": "Heena", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Ibrain", "NlmUniqueID": "9918680988706676", "ISSNLinking": "2313-1934"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harbor Perspect Biol. 2018;10(4):a033118. 10.1101/cshperspect.a033118", "ArticleIdList": ["10.1101/cshperspect.a033118", "PMC5880171", "28716886"]}, {"Citation": "Soto C, Estrada LD. Protein misfolding and neurodegeneration. Arch Neurol. 2008;65(2):184\u2010189. 10.1001/archneurol.2007.56", "ArticleIdList": ["10.1001/archneurol.2007.56", "18268186"]}, {"Citation": "Meier BP, Lappas CM. The influence of safety, efficacy, and medical condition severity on natural versus synthetic drug preference. Med Decis Making. 2016;36(8):1011\u20101019. 10.1177/0272989X15621877", "ArticleIdList": ["10.1177/0272989X15621877", "26683247"]}, {"Citation": "Karimi A, Majlesi M, Rafieian\u2010Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol. 2015;4(1):27\u201030.", "ArticleIdList": ["PMC5297475", "28197471"]}, {"Citation": "Welz AN, Emberger\u2010Klein A, Menrad K. Why people use herbal medicine: insights from a focus\u2010group study in Germany. BMC Complement Altern Med. 2018;18(1):92. 10.1186/s12906-018-2160-6", "ArticleIdList": ["10.1186/s12906-018-2160-6", "PMC5855977", "29544493"]}, {"Citation": "Nisar B, Sultan A, Rubab SL. Comparison of medicinally important natural products versus synthetic drugs:\u00a0a\u00a0short commentary. Nat\u00a0Prod\u00a0Chem\u00a0Res. 2018;06(2):308. 10.4172/2329-6836.1000308", "ArticleIdList": ["10.4172/2329-6836.1000308"]}, {"Citation": "Perrone D, Ardito F, Giannatempo G, et al. Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med. 2015;10(5):1615\u20101623. 10.3892/etm.2015.2749", "ArticleIdList": ["10.3892/etm.2015.2749", "PMC4665301", "26640527"]}, {"Citation": "Laver K, Dyer S, Whitehead C, Clemson L, Crotty M. Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews. BMJ Open. 2016;6(4):e010767. 10.1136/bmjopen-2015-010767", "ArticleIdList": ["10.1136/bmjopen-2015-010767", "PMC4854009", "27121704"]}, {"Citation": "Cheema MAR, Nawaz S, Gul S, et al. Neurochemical and behavioral effects of Nigella sativa and Olea europaea oil in rats. Nutr Neurosci. 2018;21(3):185\u2010194. 10.1080/1028415X.2016.1257417", "ArticleIdList": ["10.1080/1028415X.2016.1257417", "27868798"]}, {"Citation": "Bozda\u011f Pehlivan S. Nanotechnology\u2010based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases. Pharm Res. 2013;30(10):2499\u20102511. 10.1007/s11095-013-1156-7", "ArticleIdList": ["10.1007/s11095-013-1156-7", "23959851"]}, {"Citation": "Krol S. Challenges in drug delivery to the brain: nature is against us. J Control Release. 2012;164(2):145\u2010155. 10.1016/j.jconrel.2012.04.044", "ArticleIdList": ["10.1016/j.jconrel.2012.04.044", "22609350"]}, {"Citation": "Bhattacharya T, Soares GAB, Chopra H, et al. Applications of phyto\u2010nanotechnology for the treatment of neurodegenerative disorders. Mater. 2022;15(3):804. 10.3390/ma15030804", "ArticleIdList": ["10.3390/ma15030804", "PMC8837051", "35160749"]}, {"Citation": "Fishman JB, Rubin JB, Handrahan JV, Connor JR, Fine RE. Receptor\u2010mediated transcytosis of transferrin across the blood\u2010brain barrier. J Neurosci Res. 1987;18(2):299\u2010304. 10.1002/jnr.490180206", "ArticleIdList": ["10.1002/jnr.490180206", "3694713"]}, {"Citation": "Mohanraj VJ, Chen Y. Nanoparticles\u2014a review. Trop J Pharm Res. 2007;5(1):561\u2010573. 10.4314/tjpr.v5i1.14634", "ArticleIdList": ["10.4314/tjpr.v5i1.14634"]}, {"Citation": "De Jong J. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133\u2010149. 10.2147/ijn.s596", "ArticleIdList": ["10.2147/ijn.s596", "PMC2527668", "18686775"]}, {"Citation": "de la Torre C, Ce\u00f1a V. The delivery challenge in neurodegenerative disorders: the nanoparticles role in Alzheimer's disease therapeutics and diagnostics. Pharmaceutics. 2018;10(4):190. 10.3390/pharmaceutics10040190", "ArticleIdList": ["10.3390/pharmaceutics10040190", "PMC6321229", "30336640"]}, {"Citation": "Ngowi EE, Wang YZ, Qian L, et al. The application of nanotechnology for the diagnosis and treatment of brain diseases and disorders. Front Bioeng Biotechnol. 2021;9:629832. 10.3389/fbioe.2021.629832", "ArticleIdList": ["10.3389/fbioe.2021.629832", "PMC7960921", "33738278"]}, {"Citation": "Pardridge WM. Drug transport across the blood\u2010brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959\u20101972. 10.1038/jcbfm.2012.126", "ArticleIdList": ["10.1038/jcbfm.2012.126", "PMC3494002", "22929442"]}, {"Citation": "Ce\u00f1a V, J\u00e1tiva P. Nanoparticle crossing of blood\u2010brain barrier: a road to new therapeutic approaches to central nervous system diseases. Nanomedicine. 2018;13(13):1513\u20101516. 10.2217/nnm-2018-0139", "ArticleIdList": ["10.2217/nnm-2018-0139", "29998779"]}, {"Citation": "van Rooy I, Cakir\u2010Tascioglu S, Hennink WE, Storm G, Schiffelers RM, Mastrobattista E. In vivo methods to study uptake of nanoparticles into the brain. Pharm Res. 2011;28(3):456\u2010471. 10.1007/s11095-010-0291-7", "ArticleIdList": ["10.1007/s11095-010-0291-7", "PMC3044085", "20924653"]}, {"Citation": "Hannan MA, Rahman MA, Sohag AAM, et al. Black cumin (Nigella sativa L.): a\u00a0comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety. Nutrients. 2021;13(6):1784. 10.3390/nu13061784", "ArticleIdList": ["10.3390/nu13061784", "PMC8225153", "34073784"]}, {"Citation": "Botnick I, Xue W, Bar E, et al. Distribution of primary and specialized metabolites in Nigella sativa seeds, a spice with vast traditional and historical uses. Molecules. 2012;17(9):10159\u201010177. 10.3390/molecules170910159", "ArticleIdList": ["10.3390/molecules170910159", "PMC6268483", "22922285"]}, {"Citation": "Cascella M, Bimonte S, Barbieri A, et al. Dissecting the potential roles of Nigella sativa and its constituent thymoquinone on the prevention and on the progression of Alzheimer's disease. Front Aging Neurosci. 2018;10:16. 10.3389/fnagi.2018.00016", "ArticleIdList": ["10.3389/fnagi.2018.00016", "PMC5811465", "29479315"]}, {"Citation": "Azzubaidi MS, Saxena AK, Talib NA, Ahmed QU, Dogarai BB. Protective effect of treatment with black cumin oil on spatial cognitive functions of rats that suffered global cerebrovascular hypoperfusion. Acta Neurobiol Exp. 2012;72(2):154\u2010165.", "ArticleIdList": ["22810217"]}, {"Citation": "Hosseini A, Baradaran Rahimi V, Rakhshandeh H, Askari VR. Nigella sativa Oil reduces LPS\u2010induced microglial inflammation: an evaluation on M 1/M 2\u00a0balance. Evid Based Complementary\u00a0Altern\u00a0Med. 2022;2022:1\u201011. 10.1155/2022/5639226", "ArticleIdList": ["10.1155/2022/5639226", "PMC9213141", "35747373"]}, {"Citation": "Doolaanea AA, Mansor NI, Mohd Nor NH, Mohamed F. Co\u2010encapsulation of Nigella\u00a0sativa oil and plasmid DNA for enhanced gene therapy of Alzheimer's disease. J Microencapsul. 2016;33(2):114\u2010126. 10.3109/02652048.2015.1134689", "ArticleIdList": ["10.3109/02652048.2015.1134689", "26982435"]}, {"Citation": "Ramachandran S, Thangarajan S. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ\u2010SLNs) on 3\u2010nitroproponic acid induced Huntington's disease\u2010like symptoms in wistar rats. Chem Biol\u00a0Interact. 2016;256:25\u201036. 10.1016/j.cbi.2016.05.020", "ArticleIdList": ["10.1016/j.cbi.2016.05.020", "27206696"]}, {"Citation": "Ahmad N, Ahmad R, Alam MA, Samim M, Iqbal Z, Ahmad FJ. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia. Int J Biol Macromol. 2016;88:320\u2010332. 10.1016/j.ijbiomac.2016.03.019", "ArticleIdList": ["10.1016/j.ijbiomac.2016.03.019", "26976069"]}, {"Citation": "Yusuf M, Khan M, Alrobaian MM, et al. Brain targeted polysorbate\u201080 coated PLGA thymoquinone nanoparticles for the treatment of Alzheimer's disease, with biomechanistic insights. J Drug Delivery Sci Technol. 2021;61:102214. 10.1016/j.jddst.2020.102214", "ArticleIdList": ["10.1016/j.jddst.2020.102214"]}, {"Citation": "Ismail N, Ismail M, Azmi NH, et al. Thymoquinone\u2010rich fraction nanoemulsion (TQRFNE) decreases A\u03b240 and A\u03b242 levels by modulating APP processing, up\u2010regulating IDE and LRP1, and down\u2010regulating BACE1 and RAGE in response to high fat/cholesterol diet\u2010induced rats. Biomed Pharmacother. 2017;95:780\u2010788. 10.1016/j.biopha.2017.08.074", "ArticleIdList": ["10.1016/j.biopha.2017.08.074", "28892789"]}, {"Citation": "Nehal N, Nabi B, Rehman S, et al. Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: formulation perspective and In vitro and In vivo assessment. Int J Biiol Macromol. 2021;167:605\u2010619. 10.1016/j.ijbiomac.2020.11.207", "ArticleIdList": ["10.1016/j.ijbiomac.2020.11.207", "33278450"]}, {"Citation": "Alam M, Javed MN, Najmi AK, Ahmad FJ, Imam SS, Akhtar M. Thymoquinone lipid nanoparticles cut the gordian knots of depression via neuroprotective BDNF and downregulation of neuro\u2010inflammatory NF\u2010\u03baB, IL\u20106, and TNF\u2010\u03b1 in LPS treated rats. Curr Drug Metab. 2021;22(12):978\u2010988. 10.2174/1389200222666211108101531", "ArticleIdList": ["10.2174/1389200222666211108101531", "34749619"]}, {"Citation": "Ismail N, Ismail M, Azmi NH, et al. Beneficial effects of TQRF and TQ nano\u2010 and conventional emulsions on memory deficit, lipid peroxidation, total antioxidant status, antioxidants genes expression and soluble A\u03b2 levels in high fat\u2010cholesterol diet\u2010induced rats. Chem\u00a0Biol\u00a0Interact. 2017;275:61\u201073. 10.1016/j.cbi.2017.07.014", "ArticleIdList": ["10.1016/j.cbi.2017.07.014", "28734741"]}, {"Citation": "Xiao XY, Zhu YX, Bu JY, Li GW, Zhou JH, Zhou SP. Evaluation of neuroprotective effect of thymoquinone nanoformulation in the rodent cerebral\u00a0ischemia\u2010reperfusion model. BioMed Res Int. 2016;2016:1\u201011. 10.1155/2016/2571060", "ArticleIdList": ["10.1155/2016/2571060", "PMC5048094", "27725936"]}, {"Citation": "Ramachandran S, Thangarajan S. Thymoquinone loaded solid lipid nanoparticles counteracts 3\u2010nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease. Metab Brain Dis. 2018;33(5):1459\u20101470. 10.1007/s11011-018-0252-0", "ArticleIdList": ["10.1007/s11011-018-0252-0", "29855977"]}, {"Citation": "Jakaria M, Cho DY, Ezazul Haque M, et al. Neuropharmacological potential and delivery prospects of thymoquinone for neurological disorders. Oxid Med Cell Longevity. 2018;2018:1\u201017. 10.1155/2018/1209801", "ArticleIdList": ["10.1155/2018/1209801", "PMC5883931", "29743967"]}, {"Citation": "Pottoo FH, Ibrahim AM, Alammar A, et al. Thymoquinone: review of its potential in the treatment of neurological diseases. Pharmaceuticals. 2022;15(4):408. 10.3390/ph15040408", "ArticleIdList": ["10.3390/ph15040408", "PMC9026861", "35455405"]}, {"Citation": "Moradi SZ, Momtaz S, Bayrami Z, Farzaei MH, Abdollahi M. Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front Bioeng Biotechnol. 2020;8:238. 10.3389/fbioe.2020.00238", "ArticleIdList": ["10.3389/fbioe.2020.00238", "PMC7154137", "32318551"]}, {"Citation": "Jakaria M, Cho DY, Ezazul Haque M, et al. Neuropharmacological potential and delivery prospects of thymoquinone for neurological disorders. Oxid Med Cell Longevity. 2018;2018:1\u201017. 10.1155/2018/1209801", "ArticleIdList": ["10.1155/2018/1209801", "PMC5883931", "29743967"]}, {"Citation": "Farkhondeh T, Samarghandian S, Shahri AMP, Samini F. The neuroprotective effects of thymoquinone:\u00a0a\u00a0review. Dose\u2010Response. 2018;16(2):155932581876145. 10.1177/1559325818761455", "ArticleIdList": ["10.1177/1559325818761455", "PMC5898665", "29662431"]}, {"Citation": "Hosseinzadeh L, Monaghash H, Ahmadi F, Ghiasvand N, Shokoohinia Y. Bioassay\u2010guided isolation of neuroprotective fatty acids from Nigella sativa against 1\u2010methyl\u20104\u2010phenylpyridinium\u2010induced neurotoxicity. Pharmacogn Mag. 2017;13(52):627\u2010633. 10.4103/pm.pm_470_16", "ArticleIdList": ["10.4103/pm.pm_470_16", "PMC5701402", "29200724"]}, {"Citation": "Cobourne\u2010Duval MK, Taka E, Mendonca P, Bauer D, Soliman KFA. The antioxidant effects of thymoquinone in activated BV\u20102 murine microglial cells. Neurochem Res. 2016;41(12):3227\u20103238. 10.1007/s11064-016-2047-1", "ArticleIdList": ["10.1007/s11064-016-2047-1", "PMC5116410", "27585756"]}, {"Citation": "Khan A, Vaibhav K, Javed H, et al. Attenuation of A\u03b2\u2010induced neurotoxicity by thymoquinone via inhibition of mitochondrial dysfunction and oxidative stress. Mol Cell Biochem. 2012;369(1\u20102):55\u201065. 10.1007/s11010-012-1368-x", "ArticleIdList": ["10.1007/s11010-012-1368-x", "22752387"]}, {"Citation": "Ismail N, Ismail M, Mazlan M, et al. Thymoquinone prevents \u03b2\u2010amyloid neurotoxicity in primary cultured cerebellar granule neurons. Cell Mol Neurobiol. 2013;33(8):1159\u20101169. 10.1007/s10571-013-9982-z", "ArticleIdList": ["10.1007/s10571-013-9982-z", "24101432"]}, {"Citation": "Alhibshi AH, Odawara A, Suzuki I. Neuroprotective efficacy of thymoquinone against amyloid beta\u2010induced neurotoxicity in human induced pluripotent stem cell\u2010derived cholinergic neurons. Biochem Biophys Rep. 2019;17:122\u2010126. 10.1016/j.bbrep.2018.12.005", "ArticleIdList": ["10.1016/j.bbrep.2018.12.005", "PMC6317145", "30623116"]}, {"Citation": "Dong J, Zhang X, Wang S, et al. Thymoquinone prevents dopaminergic neurodegeneration by attenuating oxidative stress via the Nrf2/ARE pathway. Front Pharmacol. 2021;11:615598. 10.3389/fphar.2020.615598", "ArticleIdList": ["10.3389/fphar.2020.615598", "PMC7840486", "33519481"]}, {"Citation": "Firdaus F, Zafeer MF, Anis E, et al. Evaluation of phyto\u2010medicinal efficacy of thymoquinone against Arsenic induced mitochondrial dysfunction and cytotoxicity in SH\u2010SY5Y cells. Phytomedicine. 2019;54:224\u2010230. 10.1016/j.phymed.2018.09.197", "ArticleIdList": ["10.1016/j.phymed.2018.09.197", "30668372"]}, {"Citation": "Velagapudi R, El\u2010Bakoush A, Lepiarz I, Ogunrinade F, Olajide OA. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia. Mol Cell Biochem. 2017;435(1\u20102):149\u2010162. 10.1007/s11010-017-3064-3", "ArticleIdList": ["10.1007/s11010-017-3064-3", "PMC5632349", "28551846"]}, {"Citation": "Fanoudi S, Alavi MS, Hosseini M, Sadeghnia HR. Nigella sativa and thymoquinone attenuate oxidative stress and cognitive impairment following cerebral hypoperfusion in rats. Metab Brain Dis. 2019;34(4):1001\u20101010. 10.1007/s11011-019-00394-4", "ArticleIdList": ["10.1007/s11011-019-00394-4", "31016464"]}, {"Citation": "Ebrahimi SS, Oryan S, Izadpanah E, Hassanzadeh K. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease. Toxicol Lett. 2017;276:108\u2010114. 10.1016/j.toxlet.2017.05.018", "ArticleIdList": ["10.1016/j.toxlet.2017.05.018", "28526446"]}, {"Citation": "Ardah MT, Merghani MM, Haque ME. Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates \u03b1\u2010synuclein aggregation in vitro. Neurochem Int. 2019;128:115\u2010126. 10.1016/j.neuint.2019.04.014", "ArticleIdList": ["10.1016/j.neuint.2019.04.014", "31028778"]}, {"Citation": "Abulfadl Y, El\u2010Maraghy N, Ahmed AE, Nofal S, Abdel\u2010Mottaleb Y, Badary O. Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling. Hum Exp Toxicol. 2018;37(10):1092\u20101104. 10.1177/0960327118755256", "ArticleIdList": ["10.1177/0960327118755256", "29405769"]}, {"Citation": "Noor NA, Fahmy HM, Mohammed FF, Elsayed AA, Radwan NM. Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis\u2010induced Wistar rats. Int J Clin Exp Pathol. 2015;8(6):6269\u20106286.", "ArticleIdList": ["PMC4525838", "26261504"]}, {"Citation": "Sedaghat R, Roghani M, Khalili M. Neuroprotective effect of thymoquinone, the Nigella sativa bioactive compound, in 6\u2010hydroxydopamine\u2010induced hemi\u2010parkinsonian rat model. Iran\u00a0J\u00a0Pharm\u00a0Res. 2014;13(1):227\u2010234.", "ArticleIdList": ["PMC3985249", "24734075"]}, {"Citation": "Nampoothiri VPN, Sundararajan V, Dan P, Devanand Venkatasubbu G, Sheik Mohideen S. Thymoquinone as a potential therapeutic for Alzheimer's disease in transgenic Drosophila melanogaster model. Biocell. 2021;45(5):1251\u20101262. 10.32604/biocell.2021.015090", "ArticleIdList": ["10.32604/biocell.2021.015090"]}, {"Citation": "Soleimannejad K, Rahmani A, Hatefi M, Khataminia M, Hafezi Ahmadi MR, Asadollahi K. Effects of Nigella sativa extract on markers of cerebral angiogenesis after global ischemia of brain in rats. J\u00a0Stroke\u00a0Cerebrovasc\u00a0Dis. 2017;26(7):1514\u20101520. 10.1016/j.jstrokecerebrovasdis.2017.02.040", "ArticleIdList": ["10.1016/j.jstrokecerebrovasdis.2017.02.040", "28396188"]}, {"Citation": "Pottoo FH, Salahuddin M, Khan FA, et al. Thymoquinone potentiates the effect of phenytoin against electroshock\u2010induced convulsions in rats by reducing the hyperactivation of m\u2010TOR pathway and neuroinflammation: evidence from in vivo, in vitro and computational studies. Pharmaceuticals. 2021;14(11):1132. 10.3390/ph14111132", "ArticleIdList": ["10.3390/ph14111132", "PMC8618888", "34832914"]}, {"Citation": "Alam M, Najmi AK, Ahmad I, et al. Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in\u2010vitro assessment and bioactivity detail in rats. Artif Cells\u00a0Nanomed\u00a0Biotechnol. 2018;46((suppl 2)):46\u201057. 10.1080/21691401.2018.1451873", "ArticleIdList": ["10.1080/21691401.2018.1451873", "29560744"]}, {"Citation": "Nazir S, Farooq RK, Khan H, Alam T, Javed A. Thymoquinone harbors protection against Concanavalin A\u2010induced behavior deficit in BALB/c mice model. J Food Biochem. 2021;45(3):e13348. 10.1111/jfbc.13348", "ArticleIdList": ["10.1111/jfbc.13348", "32618005"]}, {"Citation": "Xue B, DasGupta D, Alam M, et al. Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy. J Cell Biochem. 2022;123(8):1381\u20101393. 10.1002/jcb.30299", "ArticleIdList": ["10.1002/jcb.30299", "35722728"]}, {"Citation": "Hyder Pottoo F, Salahuddin M, Khan FA, et al. Trio\u2010drug combination of sodium valproate, baclofen and thymoquinone exhibits synergistic anticonvulsant effects in rats and neuro\u2010protective effects in HEK\u2010293 cells. Curr Issues Mol Biol. 2022;44(10):4350\u20104366. 10.3390/cimb44100299", "ArticleIdList": ["10.3390/cimb44100299", "PMC9601194", "36286014"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "23"}, {"Year": "2023", "Month": "1", "Day": "16"}, {"Year": "2023", "Month": "1", "Day": "19"}, {"Year": "2023", "Month": "10", "Day": "3", "Hour": "6", "Minute": "48"}, {"Year": "2023", "Month": "10", "Day": "3", "Hour": "6", "Minute": "47"}, {"Year": "2023", "Month": "10", "Day": "3", "Hour": "3", "Minute": "40"}, {"Year": "2023", "Month": "2", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["37786518", "PMC10529340", "10.1002/ibra.12091", "IBRA12091"]}}], "PubmedBookArticle": []}